GoodRx Holdings, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving GoodRx Holdings, Inc. now
Current reporting with the operating signal separated from the noise.
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates
Investors are testing whether GoodRx Holdings, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.GoodRx Holdings, Inc. NASDAQ: GDRX: Investors: June 21, 2024 Filing Deadline in Securities Class Action
The story matters when it changes GoodRx Holdings, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.GoodRx Holdings, Inc. (GDRX) Misses Q1 Earnings Estimates
Investors are testing whether GoodRx Holdings, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Call Transcript
Investors are testing whether GoodRx Holdings, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest GDRX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
GoodRx Holdings, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →